General & Digestive Surgery, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
General & Digestive Surgery Service, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, Barcelona, Spain.
Am J Transplant. 2022 Apr;22(4):1169-1181. doi: 10.1111/ajt.16899. Epub 2021 Dec 21.
Postmortem normothermic regional perfusion (NRP) is a rising preservation strategy in controlled donation after circulatory determination of death (cDCD). Herein, we present results for cDCD liver transplants performed in Spain 2012-2019, with outcomes evaluated through December 31, 2020. Results were analyzed retrospectively and according to recovery technique (abdominal NRP [A-NRP] or standard rapid recovery [SRR]). During the study period, 545 cDCD liver transplants were performed with A-NRP and 258 with SRR. Median donor age was 59 years (interquartile range 49-67 years). Adjusted risk estimates were improved with A-NRP for overall biliary complications (OR 0.300, 95% CI 0.197-0.459, p < .001), ischemic type biliary lesions (OR 0.112, 95% CI 0.042-0.299, p < .001), graft loss (HR 0.371, 95% CI 0.267-0.516, p < .001), and patient death (HR 0.540, 95% CI 0.373-0.781, p = .001). Cold ischemia time (HR 1.004, 95% CI 1.001-1.007, p = .021) and re-transplantation indication (HR 9.552, 95% CI 3.519-25.930, p < .001) were significant independent predictors for graft loss among cDCD livers with A-NRP. While use of A-NRP helps overcome traditional limitations in cDCD liver transplantation, opportunity for improvement remains for cases with prolonged cold ischemia and/or technically complex recipients, indicating a potential role for complimentary ex situ perfusion preservation techniques.
在循环死亡判定后的控制器官捐献(cDCD)中, 低温区域性再灌注(NRP)是一种新兴的保存策略。本文介绍了 2012 年至 2019 年期间在西班牙进行的 cDCD 肝脏移植的结果,截至 2020 年 12 月 31 日对结果进行了评估。结果通过回顾性分析和根据恢复技术(腹部 NRP [A-NRP] 或标准快速恢复 [SRR])进行了分析。研究期间,545 例 cDCD 肝脏移植采用 A-NRP,258 例采用 SRR。供体年龄中位数为 59 岁(四分位距 49-67 岁)。调整风险估计显示,A-NRP 可降低总体胆道并发症(OR 0.300,95%CI 0.197-0.459,p<0.001)、缺血性胆道病变(OR 0.112,95%CI 0.042-0.299,p<0.001)、移植物丢失(HR 0.371,95%CI 0.267-0.516,p<0.001)和患者死亡(HR 0.540,95%CI 0.373-0.781,p=0.001)的风险。冷缺血时间(HR 1.004,95%CI 1.001-1.007,p=0.021)和再次移植指征(HR 9.552,95%CI 3.519-25.930,p<0.001)是 A-NRP 治疗的 cDCD 肝脏移植物发生移植物丢失的独立显著预测因素。尽管 A-NRP 的使用有助于克服 cDCD 肝脏移植的传统限制,但对于冷缺血时间延长和/或技术复杂的受者,仍有改进的空间,这表明补充离体灌注保存技术可能具有潜在作用。